IVIG is used in a variety of neonatal disorders, including but not limited to:
1. Hemolytic Disease of the Newborn (HDN): IVIG can reduce hemolysis and the need for exchange transfusions in neonates affected by this condition. 2. Neonatal Sepsis: While antibiotics are the primary treatment, IVIG can be used as an adjunctive therapy to boost the neonate's immune response. 3. Immune Thrombocytopenic Purpura (ITP): IVIG is used to increase platelet counts in neonates suffering from this autoimmune disorder. 4. Kawasaki Disease: Though rare in neonates, IVIG can be critical in managing this vasculitis to prevent coronary artery complications.
